TickerFacts.

Anavex Life Sciences Corp. (AVXL): R&D Expense

Annual figures by period end, from SEC filings.

$37.59M
Year ended 2025-09-30
-0.3%
3-year compound annual growth
+8.3%
5-year compound annual growth
+32.4%
10-year compound annual growth
$43.72M2010-09-30: $2.73M2011-09-30: $2.60M2012-09-30: $2.65M2013-09-30: $263.8K2014-09-30: $732.4K2015-09-30: $2.27M2016-09-30: $7.25M2017-09-30: $10.67M2018-09-30: $13.34M2019-09-30: $22.26M2020-09-30: $25.23M2021-09-30: $32.98M2022-09-30: $37.92M2023-09-30: $43.72M2024-09-30: $41.84M2025-09-30: $37.59M$37.59M
2010-09-30 R&D Expense (USD) 2025-09-30
Period endedR&D ExpenseChange YoYSource filing
2025-09-30$37.59M-10.1%2026-08-28, From 2024-10-01
2024-09-30$41.84M-4.3%2026-08-28, From 2023-10-01
2023-09-30$43.72M+15.3%2026-08-28, From 2022-10-01
2022-09-30$37.92M+15.0%2023-11-27, From 2021-10-01
2021-09-30$32.98M+30.7%2023-11-27, From 2020-10-01
2020-09-30$25.23M+13.3%2022-11-28, From 2019-10-01
2019-09-30$22.26M+66.8%2020-12-28, From 2018-10-01
2018-09-30$13.34M+25.0%2019-12-16, From 2017-10-01
2017-09-30$10.67M+47.1%2019-01-25, From 2016-10-01
2016-09-30$7.25M+219.3%2019-01-25, From 2015-10-01
2015-09-30$2.27M+210.2%2017-12-11, From 2014-10-01
2014-09-30$732.4K+177.6%2016-12-14, From 2013-10-01
2013-09-30$263.8K-90.1%2014-12-29, From 2012-10-01
2012-09-30$2.65M+2.2%2013-12-30, From 2011-10-01
2011-09-30$2.60M-4.8%2012-12-31, From 2010-10-01
2010-09-30$2.73Mn/a2011-12-22, From 2009-10-01

R&D Expense at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Anavex Life Sciences Corp. (AVXL)2025-09-30$37.59M-10.1%
Surrozen, Inc. (SRZN)2025-12-31$29.36M+39.0%
Lineage Cell Therapeutics, Inc. (LCTX)2025-12-31$17.73M+42.2%
Zura Bio Ltd (ZURA)2025-12-31$42.08M+72.5%
Quince Therapeutics, Inc. (QNCX)2025-12-31$35.38M+90.3%
aTYR PHARMA INC (ATYR)2025-12-31$60.22M+10.8%
Humacyte, Inc. (HUMA)2025-12-31$69.30M-21.8%
LeonaBio, Inc. (LONA)2025-12-31$17.50M-75.2%
Aligos Therapeutics, Inc. (ALGS)2025-12-31$69.45M-1.2%

Compare AVXL, SRZN, LCTX, ZURA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗